Product Image

Essential Iron 65 mg

4.7
★ ★ ★ ★ ★
(3300 ratings)
Iron 65 mg
Product Image
Score79
An inexpensive high-dose iron tablet suited to clinician-directed correction, not routine use without a confirmed need.
How scoring works
Tablet
Quantity:120 Tablet(s) • (120 servings)
Goals:
Energy
Hair Health
Productivity Boost

Score 79

An inexpensive high-dose iron tablet suited to clinician-directed correction, not routine use without a confirmed need.
How scoring works
$4.93($0.04 per serving)
iHerb
$ 4.93
Report prices

Analysis

Ferrous sulfate supplies 65 mg of iron in a simple one-active tablet. That amount may be useful when a clinician has identified a substantial need, but it is far beyond a light maintenance dose.

Ferrous sulfate is effective yet commonly harder on the stomach than chelated forms. Constipation, nausea, abdominal discomfort, and dark stools are practical concerns at this amount.

The clear label, large tablet count, and very low serving cost are genuine strengths. Safety and tolerability matter more than price here, so monitoring iron status is important during use.

Who is it for
  • Adults with a confirmed high iron requirement
  • People using iron under clinical monitoring
Best for
  • Clinician-directed deficiency correction
  • Low-cost high-dose iron

Pros

  • Clearly disclosed single active
  • 65 mg iron for high-requirement use
  • Very low cost per serving
  • Large tablet supply

Cons

  • Aggressive dose for routine use
  • Ferrous sulfate may be hard on digestion
  • No supporting vitamin C
  • Not suitable for casual supplementation

Warnings

  • Use 65 mg iron only for a demonstrated need because excess iron can accumulate, especially in iron-overload disorders.
  • Ferrous sulfate commonly causes constipation, nausea, stomach irritation, or dark stools at this amount.
  • Keep the tablets away from children because accidental high-dose iron ingestion is dangerous.
  • Iron can reduce absorption of levothyroxine and tetracycline or quinolone antibiotics; separate dosing according to professional guidance.

Nutrient quality

70 High impact

The iron amount is potent and directly supports deficiency-oriented use. A harsh sulfate form and aggressive dose create substantial tolerance and overdosing concerns.

Ingredient transparency

85 Highest impact

The active form and amount are clearly disclosed without a proprietary blend. Missing full use guidance and non-active tablet ingredients leave practical gaps for a high-dose product.

Customer satisfaction

72 High impact

The supplied average is strong and supported by very large response volume. No comment-level evidence is available to assess repeated complaints or alignment with the intended use.

Value for money

88 Highest impact

Very low serving cost and a clearly measured active support strong economic value. Harsh form quality and a dose unsuitable for routine use reduce practical value.

Report analysis

Goals

Energy
Impact
High effect
A Goal FitC Strength of SupportD CoverageA Formula Quality
Iron · 65 mg

The high-potency iron amount can support energy when iron deficiency limits oxygen transport. Ferrous sulfate is effective, but it is more likely to cause nausea, constipation, or stomach upset than gentler chelated forms.

The 65 mg serving is better suited to a confirmed iron need and professional guidance than casual energy use. A single-tablet formula is clear and focused, but it offers no vitamin C or blood-building cofactors.

Study evidence
Iron Supportive 74 studies
Hair Health
Impact
Moderate effect
B- Goal FitD Strength of SupportF CoverageA Formula Quality
Iron · 65 mg

Iron can help hair recovery when iron deficiency is confirmed, making the ingredient highly relevant for a specific group. The 65 mg ferrous sulfate amount is a treatment-level serving rather than routine general hair support.

People with adequate iron should not use this as a hair supplement because excess iron offers no benefit and can be harmful. The high amount commonly causes constipation or nausea and poses serious overdose risk, particularly for children.

Study evidence
Iron Disputed 25 studies
Productivity Boost
Impact
Moderate effect
C Goal FitF Strength of SupportF CoverageA- Formula Quality
Iron · 65 mg

Iron may improve energy and work capacity when deficiency is causing fatigue. The 65 mg amount is not a general productivity enhancer for people with adequate iron status.

Ferrous sulfate provides a clearly disclosed single-mineral dose without absorption cofactors. Iron can cause nausea or constipation and should not be used at this amount without a demonstrated need because excess iron can be harmful.

Study evidence
Iron Supportive 69 studies

Ingredients

IngredientAmount per serving
Iron (Ferrous Sulfate)
65 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free Vegetarian
Report overview
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

High-potency ferrous sulfate delivers a substantial iron amount at very low cost. The form may cause more digestive discomfort than chelated iron, and no absorption cofactors are included. Single-tablet convenience is strong, but the high dose is better suited to a clearly established iron need.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT · Transfusion · 2010
    Randomized trial477 participantsEnergy forIron
  2. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
    Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K · Nutrients · 2021
    Randomized trial176 participantsEnergy forIron
  3. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J; FER-ASAP investigators · Journal of perinatal medicine · 2018
    Randomized trial252 participantsEnergy forIron
  4. Effect of iron therapy on fatigue symptoms in non-anaemic iron deficient women of reproductive age- A Randomized Controlled Trial.
    Sultana N; Bajwa FA; Sikandar MZ; Haider MM; Majeed T · JPMA. The Journal of the Pakistan Medical Association · 2026
    Randomized trial164 participantsEnergy forIron
  5. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
    Holm C; Thomsen LL; Langhoff-Roos J · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2019
    Randomized trial85 participantsEnergy forIron
  6. The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case-Control Study.
    Davidovici B; Drutin Y; Ben-Tov A; Mimouni D; Wohl Y · Journal of personalized medicine · 2026
    Case-control study100,203 participantsHair Health forIron
  7. Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis.
    Treister-Goltzman Y; Yarza S; Peleg R · Skin appendage disorders · 2022
    Meta-analysis10,029 participants36 studies pooledHair Health forIron
  8. Comparative Analysis of Postoperative Hair Loss and Micronutrient Deficiencies After One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy.
    Chinisaz F; Maleki T; Najjari K; Miratashi Yazdi SA · Obesity surgery · 2026
    Cohort study261 participantsHair Health forIron
  9. Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
    Thamotharan N; Harikumar MV; Sundaram M; Swaminathan A; Rangarajan S · Cureus · 2026
    Cross-sectional study100 participantsHair Health forIron
  10. Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia.
    Lin CS; Chan LY; Wang JH; Chang CH · Tzu chi medical journal · 2023
    Cohort study155 participantsHair Health forIron
  11. Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials.
    Low M; Farrell A; Biggs BA; Pasricha SR · CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014
    Meta-analysis7,089 participants32 studies pooledProductivity Boost forIron
  12. Consumption of Iron-Biofortified Beans Positively Affects Cognitive Performance in 18- to 27-Year-Old Rwandan Female College Students in an 18-Week Randomized Controlled Efficacy Trial.
    Murray-Kolb LE; Wenger MJ; Scott SP; Rhoten SE; Lung'aho MG; Haas JD · The Journal of nutrition · 2017
    Randomized trial150 participantsProductivity Boost forIron
  13. Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China.
    Li R; Chen X; Yan H; Deurenberg P; Garby L; Hautvast JG · The American journal of clinical nutrition · 1994
    Randomized trial80 participantsProductivity Boost forIron
  14. The Effect of Iron-Fortified Lentils on Blood and Cognitive Status among Adolescent Girls in Bangladesh.
    Barnett AL; Wenger MJ; Yunus FM; Jalal C; DellaValle DM · Nutrients · 2023
    Randomized trial359 participantsProductivity Boost forIron
  15. Daily iron supplementation for improving anaemia, iron status and health in menstruating women.
    Low MS; Speedy J; Styles CE; De-Regil LM; Pasricha SR · The Cochrane database of systematic reviews · 2016
    Meta-analysis8,506 participants67 studies pooledProductivity Boost forIron